Linear IgA bullous dermatosis induced by nemvaleukin alfa, an engineered interleukin 2 molecule, in a patient with treatment-refractory metastatic melanoma

JAAD Case Rep. 2023 Sep 14:41:7-9. doi: 10.1016/j.jdcr.2023.08.040. eCollection 2023 Nov.

Authors

Fatima Bawany¹, Vignesh Ramachandran¹, Eduardo Rodriguez¹, Randie H Kim¹, Jeffrey S Weber², Ian W Tattersall¹

Affiliations

¹ Department of Dermatology, New York University, New York, New York.
² Department of Medical Oncology, New York University, New York, New York.

No abstract available

Keywords: interleukin-2; linear IgA bullous dermatosis; melanoma; nemvaleukin.

Publication types

Case Reports